Tuesday, 14 July 2026
  
Login

Australia's most trusted
source of pharma news

Tuesday, 14 July 2026
News

Shortage of chemo drugs extended

Posted 14 July 2026 AM

Shortages of Baxter Healthcare’s chemotherapies are set to continue, with all PBS listed strengths of Holoxan now expected to be impacted until mid-December.

In early February, the pharma notified the TGA of shortages of Endoxan and Holoxan, which started mid-March due to manufacturing issues and a subsequent increase in demand.

To see the whole article, please login

Popular

Ex-J&J leader lands CEO role
Novartis settles case with Zeller
Butler fires a delisting warning shot
New player moves into CSL patch
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (23)

Access & Reimbursement (1)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (3)

Other (10)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home